RU2014108253A - METHOD FOR TREATING A Focal Form of Tick-borne Encephalitis with an Extremely Heavy Course of the Acute Disease Period - Google Patents

METHOD FOR TREATING A Focal Form of Tick-borne Encephalitis with an Extremely Heavy Course of the Acute Disease Period Download PDF

Info

Publication number
RU2014108253A
RU2014108253A RU2014108253/15A RU2014108253A RU2014108253A RU 2014108253 A RU2014108253 A RU 2014108253A RU 2014108253/15 A RU2014108253/15 A RU 2014108253/15A RU 2014108253 A RU2014108253 A RU 2014108253A RU 2014108253 A RU2014108253 A RU 2014108253A
Authority
RU
Russia
Prior art keywords
tick
treating
borne encephalitis
course
extremely heavy
Prior art date
Application number
RU2014108253/15A
Other languages
Russian (ru)
Inventor
Ольга Алексеевна Громова
Владимир Александрович Семенов
Анатолий Васильевич Субботин
Данил Андреевич Этенко
Елена Геннадьевна Арефьева
Original Assignee
Ольга Алексеевна Громова
Владимир Александрович Семенов
Анатолий Васильевич Субботин
Данил Андреевич Этенко
Елена Геннадьевна Арефьева
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ольга Алексеевна Громова, Владимир Александрович Семенов, Анатолий Васильевич Субботин, Данил Андреевич Этенко, Елена Геннадьевна Арефьева filed Critical Ольга Алексеевна Громова
Priority to RU2014108253/15A priority Critical patent/RU2014108253A/en
Publication of RU2014108253A publication Critical patent/RU2014108253A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Способ лечения очаговой формы клещевого энцефалита с крайне тяжелым течением острого периода заболевания, отличающийся тем, что наряду с симптоматической терапией используют иммуноглобулин человека нормальный; иммуноглобулин человека нормальный вводят в суточной дозе 0,1 г на кг массы тела курсом 3-5 дней, независимо от дня заболевания.A method of treating a focal form of tick-borne encephalitis with an extremely severe course of the acute period of the disease, characterized in that, along with symptomatic therapy, a normal human immunoglobulin is used; normal human immunoglobulin is administered in a daily dose of 0.1 g per kg of body weight in a course of 3-5 days, regardless of the day of the disease.

Claims (1)

Способ лечения очаговой формы клещевого энцефалита с крайне тяжелым течением острого периода заболевания, отличающийся тем, что наряду с симптоматической терапией используют иммуноглобулин человека нормальный; иммуноглобулин человека нормальный вводят в суточной дозе 0,1 г на кг массы тела курсом 3-5 дней, независимо от дня заболевания. A method of treating a focal form of tick-borne encephalitis with an extremely severe course of the acute period of the disease, characterized in that, along with symptomatic therapy, a normal human immunoglobulin is used; normal human immunoglobulin is administered in a daily dose of 0.1 g per kg of body weight in a course of 3-5 days, regardless of the day of the disease.
RU2014108253/15A 2014-03-04 2014-03-04 METHOD FOR TREATING A Focal Form of Tick-borne Encephalitis with an Extremely Heavy Course of the Acute Disease Period RU2014108253A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2014108253/15A RU2014108253A (en) 2014-03-04 2014-03-04 METHOD FOR TREATING A Focal Form of Tick-borne Encephalitis with an Extremely Heavy Course of the Acute Disease Period

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2014108253/15A RU2014108253A (en) 2014-03-04 2014-03-04 METHOD FOR TREATING A Focal Form of Tick-borne Encephalitis with an Extremely Heavy Course of the Acute Disease Period

Publications (1)

Publication Number Publication Date
RU2014108253A true RU2014108253A (en) 2015-09-10

Family

ID=54073212

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014108253/15A RU2014108253A (en) 2014-03-04 2014-03-04 METHOD FOR TREATING A Focal Form of Tick-borne Encephalitis with an Extremely Heavy Course of the Acute Disease Period

Country Status (1)

Country Link
RU (1) RU2014108253A (en)

Similar Documents

Publication Publication Date Title
MX2021004828A (en) Methods of cancer treatment with antagonists against pd-1 and pd-l1 in combination with radiation therapy.
WO2016037144A3 (en) Cardiac pacing lead delivery system
PH12017500493A1 (en) Combination therapy
WO2015173633A3 (en) Hdl therapy markers
PE20190338A1 (en) METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL
MX2017011206A (en) Combination of a pd-1 antagonist and eribulin for treating cancer.
WO2015197193A3 (en) New use for jnk inhibitor molecules for treatment of various diseases
MX2017006437A (en) Spiro-isoquinoline-1,4'-piperidine compounds having multimodal activity against pain.
WO2016029136A8 (en) 3-amidobenzamides and uses thereof for increasing cellular levels of a3g
EA201692111A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DANIRYXIN FOR TREATING INFECTIOUS DISEASES
NZ745187A (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
WO2015142865A3 (en) Metakaryocidal treatments
MX2019000677A (en) B-cell-mimetic cells.
WO2017106367A8 (en) Method of treating neurodegenerative disorders by rescuing alpha-synuclein toxicity
SG10201809673RA (en) Treatment of androgen deprivation therapy associated symptoms
WO2015165964A8 (en) Treatment and prevention of alzheimer's disease (ad)
MX2019004200A (en) Combination therapy.
RU2014108253A (en) METHOD FOR TREATING A Focal Form of Tick-borne Encephalitis with an Extremely Heavy Course of the Acute Disease Period
MY183757A (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
WO2016073652A8 (en) Iminosugars useful for the treatment of viral diseases
CL2015001705A1 (en) Use of pidotimod to treat psoriasis
MX2016010919A (en) 4-benzylsulfonyl-2-butenenitrile.
UA96488U (en) A method for treating disorders of hemovascular hemostasis in patients with ischemic heart disease

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20150909